Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Anti-CRISPR AcrIIA5 Potently Inhibits All Cas9 Homologs Used for Genome Editing.

Garcia B, Lee J, Edraki A, Hidalgo-Reyes Y, Erwood S, Mir A, Trost CN, Seroussi U, Stanley SY, Cohn RD, Claycomb JM, Sontheimer EJ, Maxwell KL, Davidson AR.

Cell Rep. 2019 Nov 12;29(7):1739-1746.e5. doi: 10.1016/j.celrep.2019.10.017.

2.

Structures of Neisseria meningitidis Cas9 Complexes in Catalytically Poised and Anti-CRISPR-Inhibited States.

Sun W, Yang J, Cheng Z, Amrani N, Liu C, Wang K, Ibraheim R, Edraki A, Huang X, Wang M, Wang J, Liu L, Sheng G, Yang Y, Lou J, Sontheimer EJ, Wang Y.

Mol Cell. 2019 Dec 19;76(6):938-952.e5. doi: 10.1016/j.molcel.2019.09.025. Epub 2019 Oct 24.

PMID:
31668930
3.

A Compact, High-Accuracy Cas9 with a Dinucleotide PAM for In Vivo Genome Editing.

Edraki A, Mir A, Ibraheim R, Gainetdinov I, Yoon Y, Song CQ, Cao Y, Gallant J, Xue W, Rivera-Pérez JA, Sontheimer EJ.

Mol Cell. 2019 Feb 21;73(4):714-726.e4. doi: 10.1016/j.molcel.2018.12.003. Epub 2018 Dec 20.

PMID:
30581144
4.

NmeCas9 is an intrinsically high-fidelity genome-editing platform.

Amrani N, Gao XD, Liu P, Edraki A, Mir A, Ibraheim R, Gupta A, Sasaki KE, Wu T, Donohoue PD, Settle AH, Lied AM, McGovern K, Fuller CK, Cameron P, Fazzio TG, Zhu LJ, Wolfe SA, Sontheimer EJ.

Genome Biol. 2018 Dec 5;19(1):214. doi: 10.1186/s13059-018-1591-1.

5.

Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.

Lee J, Mir A, Edraki A, Garcia B, Amrani N, Lou HE, Gainetdinov I, Pawluk A, Ibraheim R, Gao XD, Liu P, Davidson AR, Maxwell KL, Sontheimer EJ.

mBio. 2018 Dec 4;9(6). pii: e02321-18. doi: 10.1128/mBio.02321-18.

6.

CRISPRs from scratch.

Edraki A, Sontheimer EJ.

Nat Microbiol. 2018 Mar;3(3):261-262. doi: 10.1038/s41564-018-0115-9. No abstract available.

PMID:
29463924
7.

Type II-C CRISPR-Cas9 Biology, Mechanism, and Application.

Mir A, Edraki A, Lee J, Sontheimer EJ.

ACS Chem Biol. 2018 Feb 16;13(2):357-365. doi: 10.1021/acschembio.7b00855. Epub 2017 Dec 20. Review.

8.

A Broad-Spectrum Inhibitor of CRISPR-Cas9.

Harrington LB, Doxzen KW, Ma E, Liu JJ, Knott GJ, Edraki A, Garcia B, Amrani N, Chen JS, Cofsky JC, Kranzusch PJ, Sontheimer EJ, Davidson AR, Maxwell KL, Doudna JA.

Cell. 2017 Sep 7;170(6):1224-1233.e15. doi: 10.1016/j.cell.2017.07.037. Epub 2017 Aug 24.

9.

Naturally Occurring Off-Switches for CRISPR-Cas9.

Pawluk A, Amrani N, Zhang Y, Garcia B, Hidalgo-Reyes Y, Lee J, Edraki A, Shah M, Sontheimer EJ, Maxwell KL, Davidson AR.

Cell. 2016 Dec 15;167(7):1829-1838.e9. doi: 10.1016/j.cell.2016.11.017. Epub 2016 Dec 8.

10.

Frequency of Meningitis in Children Presenting with Febrile Seizures at Ali-Asghar Children's Hospital.

Tavasoli A, Afsharkhas L, Edraki A.

Iran J Child Neurol. 2014 Fall;8(4):51-6.

Supplemental Content

Loading ...
Support Center